JP2010540570A5 - - Google Patents

Download PDF

Info

Publication number
JP2010540570A5
JP2010540570A5 JP2010527303A JP2010527303A JP2010540570A5 JP 2010540570 A5 JP2010540570 A5 JP 2010540570A5 JP 2010527303 A JP2010527303 A JP 2010527303A JP 2010527303 A JP2010527303 A JP 2010527303A JP 2010540570 A5 JP2010540570 A5 JP 2010540570A5
Authority
JP
Japan
Prior art keywords
composition
antigen
composition according
amphiphilic compound
hydrophobic carrier
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2010527303A
Other languages
English (en)
Japanese (ja)
Other versions
JP5591705B2 (ja
JP2010540570A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CA2008/001747 external-priority patent/WO2009043165A1/en
Publication of JP2010540570A publication Critical patent/JP2010540570A/ja
Publication of JP2010540570A5 publication Critical patent/JP2010540570A5/ja
Application granted granted Critical
Publication of JP5591705B2 publication Critical patent/JP5591705B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2010527303A 2007-10-03 2008-10-02 抗原、両親媒性化合物及び疎水性担体を含有する組成物、並びにその使用 Expired - Fee Related JP5591705B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US97719707P 2007-10-03 2007-10-03
US60/977,197 2007-10-03
PCT/CA2008/001747 WO2009043165A1 (en) 2007-10-03 2008-10-02 Compositions comprising an antigen, an amphipathic compound and a hydrophobic carrier, and uses thereof

Publications (3)

Publication Number Publication Date
JP2010540570A JP2010540570A (ja) 2010-12-24
JP2010540570A5 true JP2010540570A5 (enExample) 2011-11-10
JP5591705B2 JP5591705B2 (ja) 2014-09-17

Family

ID=40525804

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010527303A Expired - Fee Related JP5591705B2 (ja) 2007-10-03 2008-10-02 抗原、両親媒性化合物及び疎水性担体を含有する組成物、並びにその使用

Country Status (7)

Country Link
EP (1) EP2195022A4 (enExample)
JP (1) JP5591705B2 (enExample)
CN (1) CN101815529B (enExample)
AU (1) AU2008307042B2 (enExample)
BR (1) BRPI0817484B1 (enExample)
CA (1) CA2700828C (enExample)
WO (1) WO2009043165A1 (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5731198B2 (ja) 2007-09-27 2015-06-10 イムノバクシーン・テクノロジーズ・インコーポレイテッドImmunovaccine Technologies Inc. インビボでのポリヌクレオチドの送達のための連続疎水相を含む担体におけるリポソームの使用
CN102056622B (zh) 2008-06-05 2016-04-06 免疫疫苗技术有限公司 包含脂质体、抗原、多核苷酸和含疏水物质的连续相的载体的组合物
CN113876945A (zh) * 2011-10-06 2022-01-04 免疫疫苗技术有限公司 包括激活或增加tlr2活性的佐剂的脂质体组合物及其应用
EP2978450B1 (en) 2013-03-27 2018-09-19 ImmunoVaccine Technologies Inc. Method for improving the efficacy of a survivin vaccine in the treatment of cancer
CN107531736B (zh) 2015-01-06 2022-04-15 免疫疫苗科技公司 脂质a模拟物、其制备方法和用途
CN105044328A (zh) * 2015-05-28 2015-11-11 首都医科大学附属北京佑安医院 Elispot预包被培养板及其制备方法
CA3005127C (en) * 2015-11-18 2023-01-24 Immunovaccine Technologies Inc. Adjuvanting systems and water-free vaccine compositions comprising a polyi:c polynucleotide adjuvant and a lipid-based adjuvant
US11260116B2 (en) 2016-05-04 2022-03-01 Immunovaccine Technologies Inc. Vaccine compositions comprising an amphipathic compound, a neoantigen and a hydrophobic carrier, and methods of use thereof
CN109982715A (zh) * 2016-09-27 2019-07-05 免疫疫苗技术有限公司 利用低剂量体积b细胞表位组合物以在受试人中诱导抗体免疫应答的方法
CA3057715A1 (en) 2017-04-04 2018-10-11 Avidea Technologies, Inc. Peptide-based vaccines, methods of manufacturing, and uses thereof for inducing an immune response
EP3768242A4 (en) * 2018-03-20 2021-12-08 ImmunoVaccine Technologies Inc. METHODS AND COMPOSITIONS FOR THE TARGETED DELIVERY OF ACTIVE SUBSTANCES AND IMMUNMODULATORY AGENTS TO LYMPH NODES
AU2022224567A1 (en) * 2021-02-16 2023-08-24 Barinthus Biotherapeutics North America, Inc. Self-assembling nanoparticles based on amphiphilic peptides

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI944052A7 (fi) * 1992-03-03 1994-09-02 Daiichi Seiyaku Co Oraalinen rokote
US5736141A (en) * 1992-06-05 1998-04-07 Dalhousie University Method to prevent fertilization in mammals by administering a single dose of zona pellucida derived antigens, liposome and Freund's adjuvant
GB9422990D0 (en) * 1994-11-15 1995-01-04 Cortecs Ltd Immunogenic compositions
US6110492A (en) * 1997-05-28 2000-08-29 Jenner Biotherapies, Inc. Immunogenic compositions
US6565885B1 (en) * 1997-09-29 2003-05-20 Inhale Therapeutic Systems, Inc. Methods of spray drying pharmaceutical compositions
US6956021B1 (en) * 1998-08-25 2005-10-18 Advanced Inhalation Research, Inc. Stable spray-dried protein formulations
CA2428103C (en) * 2000-11-07 2015-06-09 Immunovaccine Technologies Inc. Vaccines with enhanced immune response and methods for their preparation
CA2523032A1 (en) * 2005-10-07 2007-04-07 Immunovaccine Technologies Inc. Vaccines for cancer therapy

Similar Documents

Publication Publication Date Title
TAN et al. Extragastrointestinal manifestations of Helicobacter pylori infection: facts or myth? A critical review
Wang et al. Engineered outer membrane vesicle is potent to elicit HPV16E7-specific cellular immunity in a mouse model of TC-1 graft tumor
He et al. Advances in aluminum hydroxide-based adjuvant research and its mechanism
RU2375374C2 (ru) Домены и эпитопы менингококкового белка nmb1870
Wang et al. Time course study of the antigen-specific immune response to a PLGA microparticle vaccine formulation
EA200901161A1 (ru) Вакцина против гриппа в виде эмульсии типа "масло в воде"
JP2011500662A5 (enExample)
Zhao et al. O/W nanoemulsion as an adjuvant for an inactivated H3N2 influenza vaccine: based on particle properties and mode of carrying
JP2010500398A5 (enExample)
ATE555808T1 (de) Impfstoffzusammensetzung mit einem synthetischen adjuvans
JP2007327074A5 (enExample)
KR102823291B1 (ko) 종양-관련된 항원 에피토프의 미생물 서열 변이체
JP2014502156A5 (enExample)
Maciel et al. Immunomodulation and nitric oxide restoration by a probiotic and its activity in gut and peritoneal macrophages in diabetic rats
JP5591705B2 (ja) 抗原、両親媒性化合物及び疎水性担体を含有する組成物、並びにその使用
JP2006232799A (ja) ポリ−γ−グルタミン酸含有免疫補強剤組成物
RU2017101091A (ru) Композиции вакцин с двойным адъювантом, получение и применения
CN106075419B (zh) 一种杀鲑气单胞菌灭活疫苗及其应用
JP2018500878A5 (enExample)
Zhu et al. Characterization and evaluation of an oral vaccine via nano-carrier for surface immunogenic protein (Sip) delivery against Streptococcus agalactiae infection
Emerson et al. Extracellular vesicles elicit protective immune responses against Salmonella infection
JP2014511856A5 (enExample)
Yu et al. A nanoparticle-based anticaries vaccine enhances the persistent immune response to inhibit Streptococcus mutans and prevent caries
Singh et al. Glycan-based shaping of the microbiota during primate evolution
PH12013500036A1 (en) Vaccine compositions based on sticholysin encapsulated into liposomes